Global Cancer Gene Therapy Market to Grow at a CAGR of 20.6 … – Business Wire (press release)
|
Global Cancer Gene Therapy Market to Grow at a CAGR of 20.6 …
Business Wire (press release) The “Global Cancer Gene Therapy Market 2017-2021” report has been added to Research and Markets’ offering. The global cancer gene therapy ma. |
Proactive Investors UK |
WideCells raises £750000 as it looks to further its penetration of growing stem cell market
Proactive Investors UK Regenerative medicines specialist WideCells Group PLC (LON:WDC) has raised £750,000 through a share placing as it looks to further its penetration of the rapidly growing stem cell market. The London-listed company has issued 5.35mln shares at 14p … WideCells Group PLC Raises £750000 to accelerate the growth of all three divisionsDirectorsTalk Interviews |
Proactive Investors UK |
WideCells raises £750000 as it looks to further its penetration of growing stem cell market
Proactive Investors UK Regenerative medicines specialist WideCells Group PLC (LON:WDC) has raised £750,000 through a share placing as it looks to further its penetration of the rapidly growing stem cell market. The London-listed company has issued 5.35mln shares at 14p … WideCells Group PLC Raises £750000 to accelerate the growth of all three divisionsDirectorsTalk Interviews |
The Bolton News |
Yasmin Qureshi MP urges Bolton residents to sign up to stem cell donor register
The Bolton News A BOLTON MP has urged more of her constituents to sign up to be stem cell donors. Yasmin Qureshi wants more people in Bolton South East to join blood cancer charity Anthony Nolan’s register, particularly men aged 16 to 30 and people from black, Asian … |
|
A revolutionary leukaemia treatment could soon be approved – here’s what it means for patients
The Independent A revolutionary gene therapy treatment for leukaemia is awaiting a thumbs-up in the US and could change the game in countering the disease. If the Food and Drug Administration (FDA) approves the treatment in September, “CTL019” will be the first gene … |
Capitol Weekly |
Stem cell agency eyes survival options
Capitol Weekly California’s $3 billion stem cell research agency, which is facing its financial demise in a few short years, has formed a team of its directors to tackle transition planning and examine possible alternatives, including ones that would extend its life … |